Business Wire06.01.18
NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., announced that the Samsung RS85 ultrasound system has received U.S. Food and Drug Administration 510(k) clearance. The RS85 is the latest expansion of Samsung’s ultrasound portfolio.
“We are pleased to launch the RS85, a new premium general imaging ultrasound system with superior image quality and usability based on Samsung’s advanced ultrasound and radiology technologies,” said Philip Sullivan, president and CEO of NeuroLogica. “The RS85 embodies Samsung’s commitment to providing leading technologies to healthcare providers by combining our key values of access, accuracy and efficiency.”
The release of the RS85 is the latest demonstration of Samsung’s leadership in ultrasound. It features an array of improvements, including:
“Samsung has built diagnostic ultrasound products for more than 30 years,” said David Legg, vice president of Sales at NeuroLogica. “We are so confident that our RS85 ultrasound system will perform reliably and be the system that you can depend on for years to come, that we are proud to offer a 5-year warranty standard, at no additional cost.”
NeuroLogica, the healthcare subsidiary of Samsung Electronics Co. Ltd., develops, manufactures, and markets imaging technologies, and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the U.S. headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s portfolio of advanced medical technologies are used worldwide in healthcare institutions, helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency.
Samsung shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, smartphones, wearable devices, tablets, digital appliances, network systems and memory, system LSI, foundry and LED solutions.
“We are pleased to launch the RS85, a new premium general imaging ultrasound system with superior image quality and usability based on Samsung’s advanced ultrasound and radiology technologies,” said Philip Sullivan, president and CEO of NeuroLogica. “The RS85 embodies Samsung’s commitment to providing leading technologies to healthcare providers by combining our key values of access, accuracy and efficiency.”
The release of the RS85 is the latest demonstration of Samsung’s leadership in ultrasound. It features an array of improvements, including:
- MV-Flow: Allows for visualization of slow-flow micro vascularized structures, which can be difficult to assess with conventional power Doppler ultrasound. It also provides clinicians an additional way to check lesions for indications of cancer or inflammation.
- S-Shearwave Imaging: Provides new indicators for clinical diagnosis by quantifying the elasticity of tissue or lesions via shearwave elastography, which may help increase the accuracy of diagnosis for breast and liver diseases.
- CEUS+: Diagnoses and characterizes lesions in the liver using a contrast agent in adult and pediatric populations.
-
S-Fusion: Enables simultaneous localization of a lesion using real-time ultrasound in conjunction with other volumetric imaging modalities such as an MRI or a CT, while expanding its capabilities to the prostate gland for precise, targeted biopsy guidance.
“Samsung has built diagnostic ultrasound products for more than 30 years,” said David Legg, vice president of Sales at NeuroLogica. “We are so confident that our RS85 ultrasound system will perform reliably and be the system that you can depend on for years to come, that we are proud to offer a 5-year warranty standard, at no additional cost.”
NeuroLogica, the healthcare subsidiary of Samsung Electronics Co. Ltd., develops, manufactures, and markets imaging technologies, and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the U.S. headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s portfolio of advanced medical technologies are used worldwide in healthcare institutions, helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency.
Samsung shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, smartphones, wearable devices, tablets, digital appliances, network systems and memory, system LSI, foundry and LED solutions.